Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06360705 · ClinicalTrials.gov registry record · NA
StrataMGT for the Treatment of Vulvar Lichen Sclerosus
A NA study, sponsored by Center for Vulvovaginal Disorders.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT06360705 is a NA study that has completed, run by Center for Vulvovaginal Disorders. The registered enrollment target is 5 participants.
The verdict
NCT06360705, a NA study, has completed, sponsored by Center for Vulvovaginal Disorders.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study is designed to evaluate the efficacy and safety of StrataMGT for the treatment of vulvar lichen sclerosus.
Interventions
- DEVICE StrataMGT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2024-04-16 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06360705
The ClinicalTrials.gov registry entry for NCT06360705 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Vulvovaginal Disorders, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which StrataMGT is the first listed.
NCT06360705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06360705 about?
NCT06360705 is a clinical study titled "StrataMGT for the Treatment of Vulvar Lichen Sclerosus". This study is designed to evaluate the efficacy and safety of StrataMGT for the treatment of vulvar lichen sclerosus.
What is the current status of trial NCT06360705?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2024-04-16. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT06360705?
The interventions under investigation include: StrataMGT (DEVICE).
Who is sponsoring clinical trial NCT06360705?
This trial is sponsored by Center for Vulvovaginal Disorders, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.